Cancers Stocks List

Symbol Grade Name % Change
AGEN F Agenus Inc. -0.68
AGIO C Agios Pharmaceuticals, Inc. -0.54
CGEN F Compugen Ltd. -1.97
CLSN F Celsion Corporation -1.82
EPZM F Epizyme, Inc. -1.05
ONCT D Oncternal Therapeutics, Inc. -2.28
HTBX F Heat Biologics, Inc. -1.04
ICAD D icad inc. -0.68
IONS F Ionis Pharmaceuticals, Inc. -4.98
MACK D Merrimack Pharmaceuticals, Inc. -0.73
ACHV F Achieve Life Sciences, Inc. -4.18
BDX C Becton, Dickinson and Company -0.70
AIM F AIM ImmunoTech Inc. -1.89
INFU C InfuSystems Holdings, Inc. -2.47
INO F Inovio Pharmaceuticals, Inc. 0.00
OPK F OPKO Health Inc. 3.03
ADXS F Advaxis, Inc. -0.54
DRNA C Dicerna Pharmaceuticals, Inc. -2.53
CBMG A Cellular Biomedicine Group, Inc. 0.00
SLRX D Salarius Pharmaceuticals, Inc. -3.23
PIRS F Pieris Pharmaceuticals, Inc. -10.14
PDSB C PDS Biotechnology Corporation -17.61
AVXL D Anavex Life Sciences Corp. -2.29
KURA F Kura Oncology, Inc. -0.20
MTP D Midatech Pharma PLC -1.81
BGNE C BeiGene, Ltd. -1.56
FLGT D Fulgent Genetics, Inc. -3.09
ZYME F Zymeworks Inc. 1.19
ATNX F Athenex, Inc. 22.64
MRSN F Mersana Therapeutics, Inc. -0.79
ALRN F Aileron Therapeutics, Inc. -4.27
NCNA F NuCana plc -2.51
CUE F Cue Biopharma, Inc. -3.35
TLSA F Tiziana Life Sciences plc 0.00
ENOB D Enochian Biosciences, Inc. 9.07
HOOK B HOOKIPA Pharma Inc. 6.13
ADPT F Adaptive Biotechnologies Corporation -2.26
IMAB C I-Mab 1.41
ORIC F Oric Pharmaceuticals, Inc. -1.27
BDXB C Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B -0.68
FMTX F Forma Therapeutics Holdings, Inc. -0.39
MDNA F Medicenna Therapeutics Corp. -5.76
HGEN C Humanigen, Inc. 5.43
GOVX B GeoVax Labs, Inc. 1.30
PMVP F PMV Pharmaceuticals, Inc. 0.85
PRLD F Prelude Therapeutics Incorporated 1.63
ONCR C Oncorus, Inc. 0.53
LIXT D Lixte Biotechnology Holdings, Inc. -2.91
BCAB F BioAtla, Inc. -0.98
EVAX D Evaxion Biotech A/S -3.16
BMEA D Biomea Fusion, Inc. 0.53
RAIN D Rain Therapeutics Inc. 0.83
VACC D Vaccitech plc -3.62
View As Page of Charts


Recent Signals

Date Stock Signal Type
2021-05-05 ACHV MACD Bearish Signal Line Cross Bearish
2021-05-05 ACHV Fell Below 200 DMA Bearish
2021-05-05 ADPT Lower Bollinger Band Walk Weakness
2021-05-05 ADPT NR7 Range Contraction
2021-05-05 AGIO Cup with Handle Other
2021-05-05 AGIO Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-05 AGIO 20 DMA Resistance Bearish
2021-05-05 AGIO Bollinger Band Squeeze Range Contraction
2021-05-05 AIM Bollinger Band Squeeze Range Contraction
2021-05-05 ATNX New Uptrend Bullish
2021-05-05 ATNX Wide Range Bar Range Expansion
2021-05-05 ATNX Volume Surge Other
2021-05-05 ATNX 50 DMA Resistance Bearish
2021-05-05 ATNX Crossed Above 20 DMA Bullish
2021-05-05 ATNX Gilligan's Island Sell Setup Bearish Swing Setup
2021-05-05 ATNX Pocket Pivot Bullish Swing Setup
2021-05-05 ATNX Slingshot Bearish Bearish Swing Setup
2021-05-05 BCAB NR7 Range Contraction
2021-05-05 BCAB Stochastic Reached Oversold Weakness
2021-05-05 BDX 50 DMA Support Bullish
2021-05-05 BDX Golden Cross Bullish
2021-05-05 BDX Hammer Candlestick Bullish
2021-05-05 BDX 200 DMA Support Bullish
2021-05-05 BDXB Narrow Range Bar Range Contraction
2021-05-05 BDXB Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-05 BGNE 20 DMA Resistance Bearish
2021-05-05 BMEA Narrow Range Bar Range Contraction
2021-05-05 BMEA Spinning Top Other
2021-05-05 CGEN Lower Bollinger Band Walk Weakness
2021-05-05 CGEN MACD Bearish Signal Line Cross Bearish
2021-05-05 CLSN 200 DMA Resistance Bearish
2021-05-05 CLSN Narrow Range Bar Range Contraction
2021-05-05 CUE Lower Bollinger Band Walk Weakness
2021-05-05 DRNA Fell Below 20 DMA Bearish
2021-05-05 DRNA MACD Bearish Signal Line Cross Bearish
2021-05-05 DRNA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-05 ENOB Pocket Pivot Bullish Swing Setup
2021-05-05 ENOB Crossed Above 50 DMA Bullish
2021-05-05 ENOB Upper Bollinger Band Walk Strength
2021-05-05 ENOB Crossed Above 200 DMA Bullish
2021-05-05 EPZM Bollinger Band Squeeze Range Contraction
2021-05-05 EPZM MACD Bearish Signal Line Cross Bearish
2021-05-05 EVAX Fell Below 20 DMA Bearish
2021-05-05 EVAX Fell Below 50 DMA Bearish
2021-05-05 EVAX Narrow Range Bar Range Contraction
2021-05-05 EVAX NR7 Range Contraction
2021-05-05 FLGT Stochastic Buy Signal Bullish
2021-05-05 FLGT 180 Bearish Setup Bearish Swing Setup
2021-05-05 FLGT Lower Bollinger Band Walk Weakness
2021-05-05 FMTX NR7 Range Contraction
2021-05-05 GOVX Pocket Pivot Bullish Swing Setup
2021-05-05 GOVX Doji - Bearish? Reversal
2021-05-05 GOVX Upper Bollinger Band Walk Strength
2021-05-05 HGEN Expansion Pivot Buy Setup Bullish Swing Setup
2021-05-05 HGEN Pocket Pivot Bullish Swing Setup
2021-05-05 HOOK Upper Bollinger Band Walk Strength
2021-05-05 HOOK Pocket Pivot Bullish Swing Setup
2021-05-05 HTBX Bollinger Band Squeeze Range Contraction
2021-05-05 HTBX 20 DMA Resistance Bearish
2021-05-05 ICAD Bollinger Band Squeeze Range Contraction
2021-05-05 IMAB MACD Bearish Signal Line Cross Bearish
2021-05-05 IMAB Pocket Pivot Bullish Swing Setup
2021-05-05 INFU Bollinger Band Squeeze Range Contraction
2021-05-05 IONS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-05 IONS Reversal New Lows Setup Bearish Swing Setup
2021-05-05 IONS New 52 Week Closing Low Bearish
2021-05-05 IONS Wide Range Bar Range Expansion
2021-05-05 IONS New 52 Week Low Weakness
2021-05-05 IONS 20 DMA Resistance Bearish
2021-05-05 KURA Bollinger Band Squeeze Range Contraction
2021-05-05 KURA Lower Bollinger Band Walk Weakness
2021-05-05 LIXT 20 DMA Resistance Bearish
2021-05-05 MACK Fell Below 50 DMA Bearish
2021-05-05 MDNA Lower Bollinger Band Walk Weakness
2021-05-05 MDNA New 52 Week Closing Low Bearish
2021-05-05 MRSN Bollinger Band Squeeze Range Contraction
2021-05-05 MTP Doji - Bearish? Reversal
2021-05-05 MTP Wide Range Bar Range Expansion
2021-05-05 MTP 200 DMA Support Bullish
2021-05-05 MTP 50 DMA Support Bullish
2021-05-05 NCNA Stochastic Reached Oversold Weakness
2021-05-05 NCNA New 52 Week Low Weakness
2021-05-05 NCNA New 52 Week Closing Low Bearish
2021-05-05 NCNA MACD Bearish Signal Line Cross Bearish
2021-05-05 ONCR Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-05 ONCR 50 DMA Support Bullish
2021-05-05 ONCR Doji - Bullish? Reversal
2021-05-05 ONCR Calm After Storm Range Contraction
2021-05-05 OPK Spinning Top Other
2021-05-05 OPK Bollinger Band Squeeze Range Contraction
2021-05-05 ORIC New Downtrend Bearish
2021-05-05 PDSB Bearish Engulfing Bearish
2021-05-05 PDSB Wide Range Bar Range Expansion
2021-05-05 PDSB 50 DMA Support Bullish
2021-05-05 PDSB MACD Bearish Signal Line Cross Bearish
2021-05-05 PDSB Bollinger Band Squeeze Range Contraction
2021-05-05 PDSB Fell Below 20 DMA Bearish
2021-05-05 PIRS New 52 Week Closing Low Bearish
2021-05-05 PIRS Expansion Breakdown Bearish Swing Setup
2021-05-05 PIRS Volume Surge Other
2021-05-05 PIRS New 52 Week Low Weakness
2021-05-05 PIRS Wide Range Bar Range Expansion
2021-05-05 PMVP Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-05 PMVP Doji - Bearish? Reversal
2021-05-05 PMVP 50 DMA Resistance Bearish
2021-05-05 PMVP Pocket Pivot Bullish Swing Setup
2021-05-05 RAIN NR7 Range Contraction
2021-05-05 SLRX 20 DMA Resistance Bearish
2021-05-05 TLSA 20 DMA Resistance Bearish
2021-05-05 VACC Hot IPO Pullback Bullish Swing Setup
2021-05-05 VACC New 52 Week Low Weakness
2021-05-05 VACC New 52 Week Closing Low Bearish
2021-05-05 ZYME Pocket Pivot Bullish Swing Setup
2021-05-05 ZYME Crossed Above 20 DMA Bullish
2021-05-05 ZYME NR7 Range Contraction

Recent News for Cancers Stocks

Date Stock Title
May 5 IONS Ionis Pharmaceuticals, Inc. (IONS) CEO Brett Monia on Q1 2021 Results - Earnings Call Transcript
May 5 FLGT Fulgent Genetics Q1 2021 Earnings Preview
May 5 ZYME Zymeworks EPS beats by $0.05, misses on revenue
May 5 ATNX Why Athenex Stock Skyrocketed Today
May 5 HGEN This Biotech Stock Could See A Big Move If It Breaks Out Of The Pennant It's Forming
May 5 ADPT Adaptive Biotechnologies EPS beats by $0.12, beats on revenue
May 5 ZYME Zymeworks Reports 2021 First Quarter Financial Results
May 5 IONS Ionis to host 2021 virtual annual meeting of stockholders
May 5 ADPT Adaptive Biotechnologies Reports First Quarter 2021 Financial Results
May 5 ATNX Why Athenex's Stock Is Trading Higher Today
May 5 FLGT Why Shares of Fulgent Genetics Fell 20% in April
May 5 EPZM Epizyme Q1 2021 Earnings Preview
May 5 BDX Becton, Dickinson Q2 2021 Earnings Preview
May 5 IONS Ionis Pharmaceuticals, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 5 HGEN Humanigen is on the rise after publication of Phase 3 data for COVID-19 therapy
May 5 HGEN Humanigen Announces Publication of Results From Phase 3 Randomized Double-Blind Placebo-Controlled Study Demonstrating the Efficacy and Safety of Lenzilumab™ in Hospitalized COVID-19 Patients
May 5 IONS Ionis Pharmaceuticals Drops on Wide Quarterly Loss
May 5 ATNX 5 Top Stock Gainers for Wednesday: Under Armour, Match, Athenex
May 5 BDXB Why Earnings Season Could Be Great for Becton, Dickinson (BDX)
May 5 BDX Why Earnings Season Could Be Great for Becton, Dickinson (BDX)

Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss and a change in bowel movements. While these symptoms may indicate cancer, they may have other causes. Over 100 types of cancers affect humans.Tobacco use is the cause of about 22% of cancer deaths. Another 10% are due to obesity, poor diet, lack of physical activity or excessive drinking of alcohol. Other factors include certain infections, exposure to ionizing radiation and environmental pollutants. In the developing world, 15% of cancers are due to infections such as Helicobacter pylori, hepatitis B, hepatitis C, human papillomavirus infection, Epstein–Barr virus and human immunodeficiency virus (HIV). These factors act, at least partly, by changing the genes of a cell. Typically, many genetic changes are required before cancer develops. Approximately 5–10% of cancers are due to inherited genetic defects from a person's parents. Cancer can be detected by certain signs and symptoms or screening tests. It is then typically further investigated by medical imaging and confirmed by biopsy.Many cancers can be prevented by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Early detection through screening is useful for cervical and colorectal cancer. The benefits of screening in breast cancer are controversial. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. Pain and symptom management are an important part of care. Palliative care is particularly important in people with advanced disease. The chance of survival depends on the type of cancer and extent of disease at the start of treatment. In children under 15 at diagnosis, the five-year survival rate in the developed world is on average 80%. For cancer in the United States, the average five-year survival rate is 66%.In 2015, about 90.5 million people had cancer. About 14.1 million new cases occur a year (not including skin cancer other than melanoma). It caused about 8.8 million deaths (15.7% of deaths). The most common types of cancer in males are lung cancer, prostate cancer, colorectal cancer and stomach cancer. In females, the most common types are breast cancer, colorectal cancer, lung cancer and cervical cancer. If skin cancer other than melanoma were included in total new cancer cases each year, it would account for around 40% of cases. In children, acute lymphoblastic leukemia and brain tumors are most common, except in Africa where non-Hodgkin lymphoma occurs more often. In 2012, about 165,000 children under 15 years of age were diagnosed with cancer. The risk of cancer increases significantly with age, and many cancers occur more commonly in developed countries. Rates are increasing as more people live to an old age and as lifestyle changes occur in the developing world. The financial costs of cancer were estimated at $1.16 trillion USD per year as of 2010.

More about Cancers
Browse All Tags